Literature DB >> 14965290

Biomedical applications of chemically and microbiologically synthesized poly(glutamic acid) and poly(lysine).

I-L Shih1, Y-T Van, M-H Shen.   

Abstract

This review article deals with the synthesis, physiochemical properties, and potential biomedical applications of two homo-poly amino acids. Poly-alpha-glutamic acid (alpha-PGA) and poly-alpha-lysine (alpha-PL) were synthesized by chemical synthesis. poly-gamma-glutamic acid (gamma-PGA) and poly-epsilon-lysine (epsilon-PL) were naturally occurring bio-materials that were produced by microbial fermentation. Poly(glutamic acid) (PGA) and poly(lysine) (PL) are water soluble, biodegradable, edible and nontoxic toward humans and the environment. As a result, they are suitable for various applications and have recently attracted considerable interest of the chemical industry. The distinguished features of PGA and PL also make them promising candidates for biomedical applications. The applications of PGA and PL in the areas of biomedical materials, drug delivery carriers and biological adhesives have been studied extensively and will be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965290     DOI: 10.2174/1389557043487420

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  19 in total

1.  Poly-alpha-glutamic acid synthesis using a novel catalytic activity of RimK from Escherichia coli K-12.

Authors:  Kuniki Kino; Toshinobu Arai; Yasuhiro Arimura
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

Review 2.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

3.  Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections.

Authors:  Bingyun Li; Bingbing Jiang; Brandon M Boyce; Brock A Lindsey
Journal:  Biomaterials       Date:  2009-02-12       Impact factor: 12.479

Review 4.  Epigenetic targets for novel therapies of lung diseases.

Authors:  Brian S Comer; Mariam Ba; Cherie A Singer; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2014-11-15       Impact factor: 12.310

5.  Characterization of an L-α,β-diaminopropionic acid polymer with comb-like structure isolated from a poly(ε-L-lysine)-producing Streptomyces sp.

Authors:  Munenori Takehara; Masayuki Saimura; Haruka Inaba; Yoshinao Kato; Shogo Muro; Tatsuki Matsunaga; Kazuya Yamanaka
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-12       Impact factor: 4.813

6.  Follow-up of multiple sclerosis patients treated with Endotherapia (GEMSP).

Authors:  Michel Geffard; Arturo Mangas; Rafael Coveñas
Journal:  Biomed Rep       Date:  2017-02-09

7.  Coacervation of poly-electrolytes in the presence of lipid bilayers: mutual alteration of structure and morphology.

Authors:  Sayantan Mondal; Qiang Cui
Journal:  Chem Sci       Date:  2022-06-16       Impact factor: 9.969

8.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

9.  Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide.

Authors:  Mahsa Jarestan; Kimia Khalatbari; Ayda Pouraei; Seyed Ataollah Sadat Shandiz; Sadaf Beigi; Mohammad Hedayati; Amitis Majlesi; Fatemeh Akbari; Ali Salehzadeh
Journal:  3 Biotech       Date:  2020-05-05       Impact factor: 2.406

Review 10.  Glutamic acid as anticancer agent: An overview.

Authors:  Satyajit Dutta; Supratim Ray; K Nagarajan
Journal:  Saudi Pharm J       Date:  2013-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.